AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion

Source Summary

AstraZeneca Plc and Bristol Myers Squibb have reportedly held preliminary discussions about a potential merger that could create one of the worlds largest pharmaceutical companies, with a combined market value approaching...